Associate Professor of Pharmacy & Pediatrics
Department Chair, Pharmacy Practice & Administrative Sciences
Executive Chair, Human Research Review Committee
Office: Nursing/Pharmacy Building, room B-64D
Phone: 505.272.5540; available Monday - Friday by appointment
Areas of Professional Interest:
Dr. Holdsworth's professional interests include research
ethics, adverse drug events and supportive care in cancer patients.
Dr. Holdsworth is a clinical pharmacist for UNM Health
Sciences Center's Pediatric Hospice Program (Mariposa Program) and Project
E.C.H.O. Pain Management clinic.
Professional Teaching for the Pharm.D. Program:
Pharmacotherapy, Oncology Block Coordinator
Safe Medication Practices, Course Coordinator
Guest Lecturer in Pathophysiology, Law & Ethics, &
Mechanisms of Drug Action
Graduate teaching for the Masters in Clinical Research Program:
Biomedical Ethics & Regulatory Compliance in Clinical Translational Research, Course Coordinator
Education & Training
l987: Doctor of Pharmacy, State University of New York at Buffalo, New York
l984: Bachelor of Science Degree in Pharmacy, University of Rhode Island, Kingston, Rhode Island
July 1987 - May 1989: Research Fellow, Department of Pharmacy Practice, College of Pharmacy, University of Arizona, Tucson, Arizona
July 1984 - June 1985: Pharmacy Resident, Montefiore Medical Center, 111 East 2l0th Street, Bronx, New York
Campaign J, Holdsworth MT. Neoplastic Diseases, In: Drug-Induced Diseases. Prevention, Detection, and Management. 2nd ed. Tisdale JE and Miller DA, eds. Pp. 1031-48. ASHP, Bethesda, 2010.
Holdsworth MT. Opioids. In: Smith KM, Riche DM, Henyan NN, eds. Clinical Drug Data, 11th ed. New York, NY: McGraw Medical; 2010:52-73.
Holdsworth MT. Antiemetics. In: Smith KM, Riche DM, Henyan NN, eds. Handbook of Clinical Drug Data, 11th ed. New York, NY: McGraw Medical; 2010:677-94.
Henry DW, Holdsworth MT, Kaiser NA. Pediatric Malignancies. In: Alldredge BK, et al, eds. Koda-Kimble and Young’s Applied Therapeutics: The Clinical Use of Drugs, 10th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2013;2143-71.
Holdsworth MT, Fichtl RE, Raisch DW, Hewryk A, Behta M, Mendez-Rico E, Wong CL, Cohen J, Bostwick S, Greenwald BM. Impact of computerized prescriber order entry on the incidence of adverse drug events in pediatric inpatients. Pediatrics 2007;120:1058-66.
Allen RC, Holdsworth MT, Johnson CA, Chavez CM, Heideman RL, Overturf G, Lemon D, Hunt WC, Winter SS. Risk determinants for catheter-associated blood stream infections in children and young adults with cancer. Pediatr Blood Cancer 2008;51:53-8.
Gluck JP, Holdsworth MT. FDA releases draft guidance on regulation of genetically engineered animals. Kennedy Inst Ethics J 2008;18:393-402.
Dupuis LL, Boodhan S, Sung L, Portwine C, Hain R, McCarthy P, Holdsworth M. Guideline for the classification of the acute emetogenic potential of antineoplastic medication in pediatric cancer patients. Pediatr Blood Cancer 2011; 57:191-8.
Mahan CE, Holdsworth MT, Welch SM, Borrego M, Spyropoulos AC. Deep-vein thombosis: a United States cost model for a preventable and costly adverse event. Thromb Haemost 2011;106:405-15.
Shoemaker, J.M., Holdsworth, M.T., Aine, C., Calhoun, V.D., de La Garza, R., Feldstein Ewing, S.W., Hayek, R., Mayer, A.R., Kiehl, K.A., Petree, L.E., Sanjuan, P., Scott, A., Stephen, J., Phillips, J.P. A practical approach to incidental findings in neuroimaging research. Neurology, 2011;77:2123-27.
Weedn V, Holdsworth, MT, Barron AM. Legal and ethical considerations in forensic pathology research. Acad Forensic Pathol 2011; 1:288-301.
Dupuis LL, Boodhan S, Sung L, Portwine C, Hain R, McCarthy
P, Holdsworth MT. Pediatric Oncology Group of Ontario
Guideline for Classification of the Acute Emetogenic Potential of
Antineoplastic Medication in Pediatric Cancer Patients.
L. Dupuis, C. Baggott, M. Holdsworth, A.M. Langevin, A. Orsey, D. Woods; COG – Cancer Control Antiemetic Committee; Lu Chen; (December 16, 2009) Guidance For COG Investigators Developing Protocols in CINV Control. https://members.childrensoncologygroup.org/Disc/cancercontrol/default.asp
The University of New Mexico’s Doctor of Pharmacy program is accredited by the Accreditation Council for Pharmacy Education, 135 LaSalle Street, Suite 4100, Chicago, IL 60603-4810, TEL (312) 664-3575 , FAX (312) 664-4652, URL http://www.acpe-accredit.org/
03/02/2012 01:22:33 PM -0700.